Abbott Laboratories against Gilead Sciences — live side-by-side technical comparison.
Prices as of 2026-11-09T20:59:59+00:00 UTC · updates daily
GILD leads 5 of the 7 windows we measure — over 1 month ABT is +11.0% and GILD +12.0%; over year to date ABT is -11.8% and GILD +38.0%. The ABT/GILD price ratio stands at 0.6528, below its 50-day average of 0.6782, and below the 200-day average of 0.7202. A ratio above its own average means ABT is gaining on GILD; on this reading the recent edge belongs to GILD.
Compare ABT and GILD: which has been stronger over the last year, and where does each stand against its 200-day average?Ask the analyst about this pair →
| ABT | GILD | |
|---|---|---|
| Price | $110.53 | $169.32 |
| 1 day | +0.6% | +1.5%lead |
| 5 days | +0.3%lead | -0.6% |
| 1 month | +11.0% | +12.0%lead |
| 6 months | +31.1%lead | +28.9% |
| Year to date | -11.8% | +38.0%lead |
| 1 year | -12.5% | +42.5%lead |
| 2 years | -5.2% | +75.3%lead |
| 52-week position | 57% of range | 88% of range |
| 52-week range | $81.97–$132.03 | $116.88–$176.58 |
| vs 50-day average | above $103.97 | above $153.51 |
| vs 200-day average | above $101.52 | above $141.13 |
| RSI (14) | 59 | 63 |
| Market cap | $190.4B | $207.0B |
| Analyst target | $118.52 (+7.8%) | $174.77 (+4.7%) |
| Analysts | 26 | 26 |
| Consensus | Buy | Buy |
| Next earnings | Jan 28, 2027 | Oct 29, 2026 |
ABT trades at $110.53, above its 50-day average of $103.97, and above the 200-day at $101.52. It sits at 57% of its 52-week range ($81.97–$132.03); 14-day RSI is 59, in neutral territory; an average session moves it about 3.2%. For levels, the first level overhead is $110.61 (0.1% away) and the first support below is $104.55 (5.4% down). On the checklist the page runs for every asset, 6 of 6 checks read bullish — the lean is bullish.
GILD trades at $169.32, above its 50-day average of $153.51, and above the 200-day at $141.13. It sits at 88% of its 52-week range ($116.88–$176.58); 14-day RSI is 63, in neutral territory; an average session moves it about 3.2%. For levels, the first level overhead is $174.48 (3.0% away) and the first support below is $153.51 (9.3% down). On the checklist the page runs for every asset, 5 of 6 checks read bullish — the lean is bullish.
Both move about the same amount day to day (3.2% and 3.2% of price), so the same position size carries comparable risk in either.
The comparison turns on those levels: ABT clearing $110.61 or losing $104.55; GILD clearing $174.48 or losing $153.51. Until one of them gives way, the relative reading above stands.